Ultrastructural examination of corneal epithelium of spontaneously obese, hyperglycemic rats

Current Eye Research

Volumn 17, Issue 11, 1998, Pages 1049-1057

  Saika, Shizuya ^a,d   Shimezaki, Mitsuo ^a   Ohkawa, Kiyomi ^a   Okada, Yuka ^a   Tawara, Akihiko ^a   Ohnishi, Yoshitaka ^a   Ooshima, Akira ^a   Kimura, Michio ^b   Kurumatani, Naomi ^c   Naka, Hiroaki ^c   Awata, Takashi ^c   Kao, Winston W Y ^d  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b Kansai Shinkyu College   (Japan)

^c SENJU PHARMACEUTICAL CO LTD   (Japan)

^d UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Corneal epithelium; Hyperglycemia; Otsuka Long Evans Tokushima fatty rat; Ultrastructure

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CELL SHAPE; CELL ULTRASTRUCTURE; CELL VACUOLE; CONTROLLED STUDY; CORNEA EPITHELIUM; CYTOPLASM; EPITHELIUM CELL; FEMALE; HEMIDESMOSOME; HYPERGLYCEMIA; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; BASEMENT MEMBRANE; EPITHELIUM, CORNEAL; FEMALE; HYPERGLYCEMIA; INTERCELLULAR JUNCTIONS; MALE; MICROSCOPY, ELECTRON, SCANNING; OBESITY; RATS; RATS, INBRED OLETF; VACUOLES;

EID: 0031766785     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.17.11.1049.5227     Document Type: Article

References (37)

1. Goodson WH III, Hunt TK. Studies of wound healing in experimental diabetes mellitus. J Surg Res. 1977;22:221-227.
2. Seifter E, Rettura G, Padawer J, Stratford F, Kambosos D, Levenson SM. Impaired wound healing in streptozotocin diabetes: prevention by supplemental vitamin A. Ann Surg. 1981;194:42-50.
3. Fukushi S, Merola LO, Tanaka M, Datiles M, Kinoshita JH. Reepithelialization of denuded corneas in diabetic rats. Exp Eye Res. 1980;31:611-621.
4. Datiles MB, Kador PF, Fukui HN, Hu T, Kinoshita JH. Corneal re-epithelialization in galactosemic rats. Invest Ophthalmol Vis Sci. 1983;24:563-569.
5. Awata T, Sogo S, Yamagami Y, Yamamoto Y. Effect of an aldose reductase inhibitor, CT-112, on healing of the corneal epithelium in galactose-fed rats. J Ocular Pharmacol. 1988;4:195-201.
6. Nakamura M, Sato N, Chikama T, Hasegawa Y, Nishida T. Fibronectin facilitates corneal epithelial wound healing in diabetic rats. Exp Eye Res. 1997;64:355-359.
7. Snip RC, Thoft RA, Tolentino FI. Similar epithelial healing rates of the corneas of diabetic and nondiabetic patients. Am J Ophthalmol. 1980;90:463-468.
8. Perry HD, Foulks GN, Thoft RA, Tolentino FI. Corneal complications after closed vitrectomy through the pars plana. Arch Ophthalmol. 1978;96:1401-1403.
9. Ohashi Y, Matsuda M, Hosotani H, et al. Aldose reductase inhibitor (CT-112) eyedrops for diabetic corneal epitheliopathy. Am J Ophthalmol. 1988;105:233-238.
10. Friend J, Ishii Y, Thoft RA. Corneal epithelial changes in diabetic rats. Ophthalmic Res. 1982;14:269-278.
11. Takahashi Y, Akagi Y, Akimune M, Tamura K, Itoi M. The role of aldose reductase in diabetic corneal epitheliopathy. Second report: The corneal epithelium of galactosemic rats. Acta Soc Ophthalmol Jpn. 1986;90:336-340.
12. Azar DT, Spurr-Michaud SJ, Tisdale AS, Gipson IK. Altered epithelial-basement membrane interactions in diabetic corneas. Arch Ophthalmol. 1992;110:537-540.
13. Taylor HR, Kimsey RA. Corneal epithelial basement membrane changes in diabetes. Invest Ophthalmol Vis Sci. 1981;20:548-553.
14. Hatchell DL, Magolan JJ Jr, Besson MJ, Goldman AI, Pederson HJ, Schulz K. Damage to the epithelial basement membrane in the corneas of diabetic rabbits. Arch Ophthalmol. 1983;101:469-471.
15. Azar DT, Gipson IK. Repair of the corneal epithelial adhesion structures following keratectomy wounds in diabetic rabbits. Acta Ophthalmol. 1989;67(suppl 192):72-79.
16. Tabatabay CA, Bumbacher M, Baumgartner B, Leuenberger PM. Reduced number of hemidesmosomes in the corneal epithelium of diabetics with proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol. 1988;226: 389-392.
17. Taylor HR, Kimsey RA. Corneal epithelial basement membrane changes in diabetes. Invest Ophthalmol Vis Sci. 1981;20:548-553.
18. Azar DT, Spurr-Michaud SJ, Tisdale AS, Gipson IK. Decreased penetration of anchoring fibrils into the diabetic stroma: a morphometric analysis. Arch Ophthalmol. 1989; 107:1520-1523.
19. Tsubota K, Chiba K, Shimazaki J. Corneal epithelium in diabetic patients. Cornea. 1991;10:156-160.
20. Hosotani H, Ohashi Y, Yamada M, Tsubota K. Reversal of abnormal corneal epithelial morphologic characteristics and reduced corneal sensitivity in diabetic patients by aldose reductase inhibitor, CT-112. Am J Ophthalmol. 1995; 119:228-294.
21. Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications. Diabetes. 1992;41:1422-1428.
22. Mori K, Takahashi Y, Tsuduki S, Kador PF, Akagi Y. Significance of aldose reductase to experimental corneal epitheliopathy. Invest Ophthalmol Vis Sci. 1994;35(suppl):1946.
23. Yokoi N, Niiya A, Komuro A, et al. Effects of aldose reductase inhibitor CT-112 on the corneal epithelial barrier of galactose-fed rats. Curr Eye Res. 1997;16:595-599.
24. Göbbels M, Spitznas M, Oldendoerp J. Impairment of corneal epithelial barrier function in diabetics. Graefes Arch Clin Exp Ophthalmol 1989;227:142-144.
25. Kinoshita JH. Cataracts in galactosemia. Invest Ophthalmol. 1965;4:786-799.
26. Kinoshita JH. Mechanism initiating cataract formation. Invest Ophthalmol Vis Sci. 1974;13:713-724.
27. Akagi Y, Yajima Y, Kador PF, Kuwabara T, Kinoshita JH. Localization of aldose reductase in the human eye. Diabetes. 1984;33:562-566.
28. Awata T, Sogo S, Yamamoto Y. Effects of aldose reductase inhibitor CT-112 on sugar alcohol accumulation in corneal epithelium of galactose-fed rats. Jp J Ophthalmol. 1986; 30:245-250.
29. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation and products in tissue and the biochemical basis of diabetic complications. N Eng J Med. 1988;20:1315-1321.
30. Lee TS, Saltsman KA, Ohashi H, King GL. Activation of protein kinase by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci USA. 1989;86: 5141-5145.
31. Inoguchi T, Batten R, Handler E, Sportsman JR, Heath W, King GL. Preferential elevation of protein kinase C isoform β II and diacylglycerol levels in the aorta and heart of diabetic rats. Proc Natl Acad Sci USA. 1992;89:11059-11063.
32. Xia P, Inoguchi T, Kern TS, Engerman RL, Oates PJ. Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes. 1994;43:1122-1129.
33. Fumo P, Kuncio GS, Ziyadeh FN. PKC and high glucose stimulate collagen alpha 1(IV) transcriptional activity in a reporter mesangeal cell line. Am J Physiol. 1994;267: F632-638.
34. Sharma K, Ziyadeh FN. Hyperglycemia and diabetic kidney disease: the case for transforming growth factor-β as a key mediator. Diabetes. 1995;44:1139-1146.
35. Wahab NA, Harper K, Mason RM. Expression of extracellular matrix molecules in human mesangial cells in response to prolonged hyperglycaemia. Biochem J. 1996; 316:985-992.
36. McClain DA, Paterson AJ, Roos MD, Wei X, Kudlow JE. Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells. Proc Natl Acad Sci USA. 1992;89:8150-8154.
37. Tseng SCG, Li D-Q. Comparison of protein kinase C subtype expression between normal and aniridic human ocular surfaces: implications for limbal stem cell dysfunction in aniridia. Cornea. 1996;15:168-178.